[H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease].
The efficacy of the administration of famotidine, 20 mg BID, at early stages of gastroduodenal reflux disease (GDRD) based on a clinical and endoscopy study and treatment of patients of 0 and 1 degrees on the modified Savary-Miller scale.